ERBB2 and breast cancer: A potent tumor-killing effect associated with elevated levels of apoptotic cell death markers was reported for LA against SKBR3, MCF-7, and HER2-positive breast cancer cell lines, with the downregulation of FAS and HER2 levels [22,23].